A NEW IDEA ON CARLSMED (CARL) — AI ENABLED PERSONALIZED SPINE SURGERY
By Nigam Arora & Dr. Natasha Arora
CARL is a pioneer in AI enabled personalized spine surgery. The company aims to become the standard of care for spine fusion surgery.
IPO
The company just conducted its IPO. The IPO was priced at $15.
Opening Indication
The opening indication is $14.
Zones
The buy zone is $*** (To see the locked content, please take a 30 day free trial) – $*** to scale in. Please see Trade Management Guidelines on how to properly scale in.
The maximum position size is ***% of the full core position size in the above buy zone.… Please click here or the title below to read more.
July 24, 2025